Jubilant HollisterStier plans US $92 mn expansion
The 50,000 square foot expansion will house a high-speed filling line and lyophilizers, which will increase the facility’s sterile injectable capacity by 50%
The 50,000 square foot expansion will house a high-speed filling line and lyophilizers, which will increase the facility’s sterile injectable capacity by 50%
Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
Expands wound care portfolio and aims to drive greater market penetration and availability in the wound dressing category
The implant is surgically inserted into the eye during a one-time, outpatient procedure and refilled every six months
The platform will be a curated marketplace for sustainable-driven products by small-medium entrepreneurs and will encourage an autonomous marketplace
The company’s pharmaceutical API products Ibuprofen and fenofibrate got the go-ahead
If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19
Subscribe To Our Newsletter & Stay Updated